18
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Anti-neutrophil cytoplasmic autoantibodies against bactericidal/permeability-increasing protein in patients with rheumatoid arthritis and their correlation with bronchial involvement

, , , &
Pages 252-256 | Received 02 Sep 2009, Accepted 15 Dec 2009, Published online: 02 Jan 2014

References

  • Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and char-acterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978;253:2664–72.
  • Zhao MH, Jones SJ, Lockwood CM. Bactericidal/permeability increasing protein (BPI) is an important antigen for anti-neutro-phil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol. 1995;99:49–56.
  • Schultz H. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimmun Rev. 2007;6:223–7.
  • Schultz H, Weiss J, Carroll SF, Gross WL. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies. J Leukoc Biol. 2001;69:505–12.
  • Mahadeva R, Dunn AC, Westerbeek RC, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/perme-ability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol. 1999;117:561–7.
  • Shinke S, Fellermann K, Herlyn K, et al. Autoantibodies against the bactericidal/permeability-increasing protein (BPI) from inflammatory bowel disease patients can impair the antibiotic activity of BPI. Inflamm Bowel Dis. 2004;10:763–70.
  • Manolova I, Dancheva M, Halacheva K. Antineutrophil cyto-plasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheu-matol Int. 2001;20:197–204.
  • Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic auto-antibodies in systemic sclerosis. J Rheumatol. 2003;30:1248–52.
  • Manolova I, Dantcheva M. Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations. Rheumatol Int. 2005;26:107–14.
  • Ohtami S, Kobayashi O, Ohtami H. Analysis of intractable fac-tors in chronic airway infections: role of the autoimmunity induced by BPI-ANCA. J Infect Chemother. 2001;7:228–38.
  • Bilgici A, Ulusoy H, Kuru O, Celenk C, Unsal M, Danaci M. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int. 2005;25:429–35.
  • Vergnenegre A, Pugnere N, Antonini MT, et al. Airway obstruction and rheumatoid arthritis. Eur Resp J. 1997;10: 1072–8.
  • Swinson DR, Symons D, Suresh U, Jones M, Booth M. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol. 1997;36:689–91.
  • Kobayashi H. Airway biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. J Infect Chemother. 1995;1:1–15.
  • Blander JM, Medzhiov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature. 2006; 440:808–12.
  • Mustila A, Paimela L, Leirisalo-Repo M, Huhtala H, Miettinen A. Antineutrophil cytoplasmic antibodies in patient with early rheumatoid arthritis. Arthritis Rheum. 2000;43:1371–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.